Virtual reality
DeviceA range of virtual reality software, delivered through the "DR.VR" (TM) device.
NCT Number: NCT06534580
Background
Pain is commonly experienced by people who are living with advanced (incurable) cancer. There is evidence to suggest virtual reality could help to relieve this pain: however, this evidence is poor quality with the intervention poorly defined. A robustly co-designed intervention, with people who have advanced cancer and experience pain, will facilitate a better evidence-base.
Aim
To develop and refine a virtual reality intervention that will help people living with advanced cancer to manage pain.
Objectives
1. Explore and establish key components of a virtual reality intervention for people with advanced cancer in terms of effectiveness, acceptability and feasibility using in-depth interviews and focus groups with people living with advanced cancer and experiencing pain. 2. Develop and manualise a virtual reality intervention using co-design methodology. 3. User-test the intervention to refine further.
Methods
Multi-method design, incorporating multiple stakeholder perspectives, over three phases:
Phase I. Focus groups or individual interviews with a total of 40 people, from four locations (Brighton, Cardiff, Liverpool, & London), who have advanced cancer and experience pain.
They will use the virtual reality intervention and give feedback on what resonated with them and what they would change.
Phase II. Four focus groups (one at each study location) with multiple stakeholders. During this stage, the findings from phase 1 will be presented and a manual will be produced that gives guidelines on use of the virtual reality intervention.
Phase III. Up to 20 people living with advanced cancer and pain will user-test the intervention over an eight-week period. During this phase, the investigators will test if/how often the virtual reality is used as part of routine practice in each site and identify any barriers of use.
Anticipated Impact and Dissemination
1. A robustly co-designed intervention, ready for testing in a larger trial, to assess the clinical and cost effectiveness of virtual reality as a form of pain management. 2. Guidelines for the use of virtual reality in a clinical setting.
The results will be published through academic routes (peer-reviewed publications as well as presented at national and international conferences). The investigators will also work with our group of people with lived experience and an oversight committee to establish the best other routes to disseminate the findings to the public e.g., a social media campaign, leaflets to clinical settings, blog and vlog posts.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients will be considered eligible to participate if:
Professional/staff participants will be considered eligible if:
Exclusion criteria
Patients will be excluded if:
Professional/staff participants will be excluded if:
We will document reasons for not participating, where offered.
A range of virtual reality software, delivered through the "DR.VR" (TM) device.
Time frame: 15 months
Time frame: 15 months
Time frame: 15 months
University College, London
Other
Developing and Refining a Virtual Reality Intervention That Will Help to Manage Pain for People Living With Advanced Cancer
Acronym: VRcan
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04307914
Bone Cancer, Bone Diseases
Turku, Finland
View Trial DetailsNCT04310410
Bone Cancer, Bone Diseases
Zwolle, Overijsel, Netherlands
View Trial DetailsNCT03374592
Neoplasm Metastasis, Neoplasms
View Trial DetailsNCT02511678
Bone Metastasis of Diverse Origins, Neoplasm Metastasis
Los Angeles, California, United States
View Trial Details